A technology for the treatment of acne that was invented by faculty at LSU Health New Orleans is being acquired by Allergan, the $23 billion pharmaceutical company best known as the maker of Botox.
Allergan acquired Anterios, a clinical-stage pharmaceutical company that had licensed an LSU Health-patented technology in 2008. The school holds equity in the technology.
The deal means that Allergan, which last year agreed to merge with Pfizer to create the world’s largest pharmaceutical company, will pay Anterios $90 million upfront as well as potential development and milestone payments.
As a former equity holder in Anterios, LSU Health New Orleans will receive a share of the upfront payment and a share of any payments if additional milestones are reached.